Strategic networks
LUCC has 17 strategic translational networks based on cancer diagnosis, technology or processes. The aim of the networks is to bridge the basic and clinical science and the diverse disciplines. Networking activities include discussions about scientific challenges in the field, facilitation of new collaborations, and sharing technical and educational expertise. The key goal is to create opportunities that set the foundation for novel interdisciplinary research collaboration.
LUCC 17 translational networks (diagnosis, technology, or process-oriented):
- Breast (Sophie Lehn / Ida Skarping)
- Child (Daniel Bexell / Charlotte Böiers / Kees-Jan Pronk)
- CNS (Alexander Pietras / Johan Bengzon)
- Gastrointestinal - Colorectal (Milladur Rahman/ Pamela Buchwald / Marie-Louise Lydrup) - Hepatic-Pancreatic-Biliary (HPB) (Monika Bauden / Daniel Ansari)
- Gynecology (Ingrid Hedenfalk / Susanne Malander)
- Head & neck (Malin Lindstedt / Lennart Greiff & Maria Gebre-Medhin)
- Hematology (Anna Hagström / Jörg Cammenga)
- Lung (Mattias Magnusson / Maria Planck)
- Sarcoma (Karolina Leandersson Bogefors / Fredrik Mertens)
- Skin (Göran B Jönsson / Henrik Ekedahl)
- Urology: Prostate-Bladder-Kidney (Yvonne Ceder / Fredrik Liedberg)
- Cancer prevention (Helena Jernström / Annika Kisch)
- Diagnosis & clinical trials (Lao Saal / Mats Jerkeman)
- Imaging & nuclear medicine/radiology (Ramin Massoumi / Ida Skarping)
- Immunotherapy & tumour microenvironment (Anna Gerdtsson / Kristina Lundberg / Niels-Bjarne Woods)
- Nursing, rehabilitation and palliative care (Marlene Malmström / Annika Kisch)
- Cancer epidemiology (Helena Jernström / Tanja Stocks)
Contact respective heads if you want to participate in any of the strategic translational networks.